The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
Related Posts
Oil Prices Rise as Trump Meets China’s Xi
The president is expected to urge the Chinese leader to help ease tensions in the Middle East by helping to…
Will Writing Survive A.I.? The Media Startup Every Is Betting on It.
The start-up Every centered its business model on artificial intelligence, and has raised $2 million from backers including Reid Hoffman,…
A Devastating Trade Spat With China Shows Few Signs of Abating
The Trump administration is in a standoff with the Chinese government as trade tensions escalate, leaving U.S. businesses in the…